Jaglix 50 mg filmom obložene tablete
| Name | Jaglix 50 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-044641706 |
| Active Substance | sitagliptinklorid hidrat |
| Composition | jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Mylan Hungary Kft, Komárom, Mađarska Medis International A.S., Bolatice, Češka McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin, Dublin, Irska |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 02.11.2022 |
| MA Period of Validity | 23.04.2026 |
| Classification Number | UP/I-530-09/19-01/283 |
| Registration Number | 381-12-01/154-22-14 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A10BH01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
